IFIH1 and dermatomyositis: Rheumatologists should be cautious about the development of SIH in DM patients with lung involvement, presence of dysphagia, heparin used, very high doses of steroids given, positive for MDA5 antibody, and/or anti-Ro52 especially in the early stage of the diagnosis of DM.